Cato Institute

Fannie Mae, Freddie Mac, and Housing Finance: Why True Privatization Is Good Public Policy

Lawrence J. White
October 7, 2004

In this Policy Analysis, Lawrence White writes that the Federal National Mortgage Association (Fannie Mae) and the Federal Home Loan Mortgage Corporation (Freddie Mac) are the two dominant entities

Peer-to-Peer Networking and Digital Rights Management: How Market Tools Can Solve Copyright Problems

Michael A. Einhorn and Bill Rosenblatt
February 17, 2005

In this CATO Policy Analysis, the authors write that the term “peer to peer” (P2P) refers generally to software that enables a computer to locate a content file on another networked device and copy

Who Killed Telecom? Why The Official Story Is Wrong

Lawrence Gasman
February 7, 2005

In this Policy Analysis, Gasman states that in the mid-1990s as it seemed that lawmakers were about to abandon much of the regulatory apparatus that had hampered the telecommunications industry sin

Five Myths of Socialized Medicine

John Goodman
January 1, 2005

In this essay in CATO's Letter, John Goodman writes that in the United States there are about 14 million people—more than a third of the uninsured—who are, in principle, eligible to get free m

When Ignorance Isn't Bliss: How Political Ignorance Threatens Democracy

Ilya Somin
September 22, 2004

In this Policy Analysis, the author writes at CATO that democracy demands an informed electorate. Voters who lack adequate knowledge about politics will find it difficult to control public policy.

Health Care Regulation: A $169 Billion Hidden Tax

Christopher J. Conover
October 4, 2004

In this Policy Analysis, Chris Conover writes that the burden of regulation on the U.S. economy is sizable, with the latest figures suggesting this cost may approach $1 trillion in 2004.

Three Myths about VoteTurnout in the United States

John Samples
September 14, 2004

In this Policy Analysis, John Samples examines voter turnout and elections.  He asserts that critics of American politics and elections often focus on low voter turnout in the United States.

Is There A Biomedical Anticommons?

Richard A. Epstein and Bruce N. Kuhlik
June 1, 2004

This essay in CATO's Regulation magazine investigates patent law of whether patent protection could deter biomedical research.

Understanding Privacy--and the Real Threats To It

Jim Harper
August 4, 2004

In this Policy Analysis, the author writes that properly defined, privacy is the subjective condition people experience when they have power to control information about themselves.

Drug Reimportation: The Free Market Solution

Roger Pilon
August 4, 2004

In this Policy Analysis, Roger Pilon writes that as pharmaceuticals play a growing role in medical practice, drug prices in America soar far beyond prices in the rest of the world.

Syndicate content